The popular and experimental drugs called peptides received unprecedented attention last month during a marathon hearing held by a panel that advises the Food and Drug Administration. Catherine Falls Commercial/Getty Images hide caption toggle caption Catherine Falls Commercial/Getty Images The peptide saga has reached what could be its most confusing chapter — at least for